Autoimmunity BioSolutions
Develops genetically-guided therapy targeting sIL7R to treat autoimmune diseases including RA and lupus
$1MSeed+
Role not disclosedLoading investors…
Activity from announced rounds
Develops genetically-guided therapy targeting sIL7R to treat autoimmune diseases including RA and lupus